Mark Stock Price: Remark Holding inc looks to break losing streak amid AI, coronavirus hopes and fears

Remark Holdings´stock price has been falling for four consecutive days.
Hopes and concerns about its AI technology are eyed.
Elevate usage of thermal scanners for reopening the economies also provides hope.

What goes around comes around – at least partially. NASDAQ: MARK surged from around $0.50 in early May to a close of $3.40 on May 27 but has been falling in the past four trading sessions. At a closing price of $2.24 on Tuesday, shares of the Las Vegas-based firm are already down by around a third.

Pre-market trading suggests a recovery, albeit a modest one.

Mark stock news

The most recent development came via a partnership to supply Artificial Intellenginece technology in China. While the world's second-largest economy is a vast market, some have raised concerns that collaborating with a country that is becoming growingly authoritarian and follows its citizens too closely may backfire.

The anti-China sentiment is rife in America, primarily driven by President Donald Trump, but also egged on by Democrats. That may limit the firm's ability to expand.

The bulk of the surge came from the usage of MARK's thermal scanners for monitoring potential COVID-19 patients. The devices can run over 120 people per minute, which it claims to be ten times faster than more expensive manual fever measurements.

Nevertheless, the kit is used only for the reopening phase. If things improve, the equipment may become useless. And if a second wave hits Western countries, they may reimpose lockdowns, removing the need for scanning, or at least limiting its scope.

Overall, Remark Holdings Inc faces sobering challenges that put in doubt the recent enthusiasm. On the other hand, the company is worth only around $222 million according to its close price. Showing decent revenues from its products may cause a rethink and send shares to a higher valuation.

Share: Feed news

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.